CITIUS ONCOLOGY INC (CTOR) Stock News

NASDAQ:CTOR - US17331Y1091 - Common Stock

1.89 USD

+0.02 (+1.07%)

Last: 9/11/2025, 8:00:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

CTOR Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: Citius Oncology, Inc. - Mentions: CTXR

Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement

4 days ago - By: Benzinga - Mentions: ACRV TONX SSM OCTO ...

Why Robinhood Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket

9 days ago - By: Benzinga - Mentions: BRKR SLRX PPCB LUNG ...

12 Health Care Stocks Moving In Tuesday's After-Market Session

21 days ago - By: Citius Oncology, Inc. - Mentions: CTXR

Citius Oncology Deploys AI Platform to Amplify the Performance of its Commercial Team Ahead of LYMPHIR Launch

a month ago - By: The Motley Fool

Citius Oncology Beats Fiscal Q3 EPS

a month ago - By: Citius Oncology, Inc.

Citius Oncology, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update

2 months ago - By: Citius Oncology, Inc. - Mentions: CTXR

Citius Oncology Announces Closing of $9.0 Million Public Offering

2 months ago - By: Citius Oncology, Inc. - Mentions: CTXR

Citius Oncology Announces Pricing of $9.0 Million Public Offering

2 months ago - By: Citius Oncology, Inc. - Mentions: CTXR

Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora

3 months ago - By: Citius Oncology, Inc. - Mentions: CTXR

Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025